Celik I - Search Results

1

Pathologic thrombopoiesis of rheumatoid arthritis.

Ertenli I, Kiraz S, Oztürk MA, Haznedaroğlu Ic, Celik I, Calgüneri M. Ertenli I, et al. Among authors: celik i. Rheumatol Int. 2003 Mar;23(2):49-60. doi: 10.1007/s00296-003-0289-0. Epub 2003 Feb 11. Rheumatol Int. 2003. PMID: 12634936 Review.

2

Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis.

Kiraz S, Ertenli I, Oztürk MA, Haznedaroglu IC, Calgüneri M, Atalar E, Ozbalkan Z, Kirazli S, Celik I. Kiraz S, et al. Among authors: celik i. J Rheumatol. 2003 Feb;30(2):313-5. J Rheumatol. 2003. PMID: 12563687

3

Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behçet's disease.

Oztürk MA, Ertenli I, Kiraz S, C Haznedaroğlu I, Celik I, Kirazli S, Calgüneri M. Oztürk MA, et al. Among authors: celik i. Rheumatol Int. 2004 Mar;24(2):98-102. doi: 10.1007/s00296-003-0324-1. Epub 2003 May 15. Rheumatol Int. 2004. PMID: 12750940

4

Pathological haemostasis and "prothrombotic state" in Behçet's disease.

Kiraz S, Ertenli I, Oztürk MA, Haznedaroğlu IC, Celik I, Calgüneri M. Kiraz S, et al. Among authors: celik i. Thromb Res. 2002 Jan 15;105(2):125-33. doi: 10.1016/s0049-3848(02)00006-3. Thromb Res. 2002. PMID: 11958802 Review.

5

Changes in the concentration and distribution of tissue factor pathway inhibitor in Behçet's disease and systemic lupus erythematosus: effect on the prethrombotic state.

Ertenli I, Kiraz S, Celik IC, Haznedaroglu C, Erman M, Calgüneri M, Kirazli S. Ertenli I, et al. Among authors: celik ic. Ann Rheum Dis. 2001 Dec;60(12):1149-51. doi: 10.1136/ard.60.12.1149. Ann Rheum Dis. 2001. PMID: 11709459 Free PMC article.

6

Cytarabine-induced fever complicating the clinical course of leukemia.

Gonen C, Celik I, Cetinkaya YS, Haznedaroglu I. Gonen C, et al. Among authors: celik i. Anticancer Drugs. 2005 Jan;16(1):59-62. doi: 10.1097/00001813-200501000-00008. Anticancer Drugs. 2005. PMID: 15613905

7

Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences.

Abali H, Haznedaroglu IC, Goker H, Celik I, Ozatli D, Koray Z, Caglar M. Abali H, et al. Among authors: celik i. Hematology. 2002 Apr;7(2):75-82. doi: 10.1080/10245330290022160. Hematology. 2002. PMID: 12186695

8

Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatin.

Oztürk MA, Barişta I, Altundağ MK, Türker A, Yalçin S, Celik I, Güllü I, Güler N, Ozişik Y, Kars A, Kansu E, Baltali E, Tekuzman G. Oztürk MA, et al. Among authors: celik i. Chemotherapy. 2002 Dec;48(5):252-8. doi: 10.1159/000066768. Chemotherapy. 2002. PMID: 12476042 Clinical Trial.

9

Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significance.

Dizdar O, Erman M, Cankurtaran M, Halil M, Ulger Z, Yavuz BB, Ariogul S, Pinar A, Harputluoglu H, Kars A, Celik I. Dizdar O, et al. Among authors: celik i. Ann Hematol. 2008 Jan;87(1):57-60. doi: 10.1007/s00277-007-0376-5. Epub 2007 Sep 14. Ann Hematol. 2008. PMID: 17874101

10

Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data.

Özdemir N, Dizdar Ö, Yazıcı O, Aksoy S, Dede DS, Budakoğlu B, Metan G, Alp A, Budakoğlu II, Öksüzoğlu ÖBÇ, Özet A, Kılıçkap S, Turhal NS, Çelik İ, Erman M, Ata N, Çelik O, Hayran M. Özdemir N, et al. Among authors: celik i, celik o. Int J Cancer. 2021 May 15;148(10):2407-2415. doi: 10.1002/ijc.33426. Epub 2020 Dec 17. Int J Cancer. 2021. PMID: 33284987 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

693 results

Search Page